| Jason Vinh Nguyen, MD | |
|
3151 W Tecumseh Rd Ste 230, Norman, OK 73072-1846 | |
| (888) 323-3937 | |
| Not Available |
| Full Name | Jason Vinh Nguyen |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 8 Years |
| Location | 3151 W Tecumseh Rd Ste 230, Norman, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679000749 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 32976 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jay C. Johnston, M. D., Inc | 0143491506 | 2 |
News Archive
A student-led team from The University of Texas at San Antonio is the beneficiary of a $50,000 grant to UTSA's CITE program from the National Science Foundation to support the continued development of their infrared medical camera, InfraVein, which makes simple work of finding veins.
By launching Sona, the Sonova Group is introducing a novel business concept combining a specialized product portfolio with easy fitting and simplified logistic processes, which are unique in the industry. The new brand broadens the portfolio of the established hearing solutions of Phonak and Unitron and is aimed at the market segment for mild-to-moderate hearing loss. It features mainly the integrated service concept providing audiologists with new opportunities to make their hearing solutions more accessible to consumers.
Results from a Phase 1b/2 trial suggest that an investigational microbiome-based, oral therapeutic drug is effective for the treatment of recurrent C. difficile infection. In a paper published online in the Journal of Infectious Diseases, a multi-institutional research team reports that treatment with the preparation, containing the spores of approximately 50 species of beneficial bacteria, successfully prevented recurrence of C. difficile infection (CDI) in patients with a history of multiple recurrent disease.
Biothera will present research at the American Society of Clinical Oncology annual meeting linking a potential predictive serum biomarker to the clinical response to Imprime PGG immunotherapy in a recent phase 2 study in non-small cell lung cancer patients. The meeting begins today and runs through June 3 in Chicago.
› Verified 2 days ago
| Entity Name | Britton Vision Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427051408 PECOS PAC ID: 4688659519 Enrollment ID: O20040623000902 |
News Archive
A student-led team from The University of Texas at San Antonio is the beneficiary of a $50,000 grant to UTSA's CITE program from the National Science Foundation to support the continued development of their infrared medical camera, InfraVein, which makes simple work of finding veins.
By launching Sona, the Sonova Group is introducing a novel business concept combining a specialized product portfolio with easy fitting and simplified logistic processes, which are unique in the industry. The new brand broadens the portfolio of the established hearing solutions of Phonak and Unitron and is aimed at the market segment for mild-to-moderate hearing loss. It features mainly the integrated service concept providing audiologists with new opportunities to make their hearing solutions more accessible to consumers.
Results from a Phase 1b/2 trial suggest that an investigational microbiome-based, oral therapeutic drug is effective for the treatment of recurrent C. difficile infection. In a paper published online in the Journal of Infectious Diseases, a multi-institutional research team reports that treatment with the preparation, containing the spores of approximately 50 species of beneficial bacteria, successfully prevented recurrence of C. difficile infection (CDI) in patients with a history of multiple recurrent disease.
Biothera will present research at the American Society of Clinical Oncology annual meeting linking a potential predictive serum biomarker to the clinical response to Imprime PGG immunotherapy in a recent phase 2 study in non-small cell lung cancer patients. The meeting begins today and runs through June 3 in Chicago.
› Verified 2 days ago
| Entity Name | Jay C. Johnston, M. D., Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649482951 PECOS PAC ID: 0143491506 Enrollment ID: O20110915000788 |
News Archive
A student-led team from The University of Texas at San Antonio is the beneficiary of a $50,000 grant to UTSA's CITE program from the National Science Foundation to support the continued development of their infrared medical camera, InfraVein, which makes simple work of finding veins.
By launching Sona, the Sonova Group is introducing a novel business concept combining a specialized product portfolio with easy fitting and simplified logistic processes, which are unique in the industry. The new brand broadens the portfolio of the established hearing solutions of Phonak and Unitron and is aimed at the market segment for mild-to-moderate hearing loss. It features mainly the integrated service concept providing audiologists with new opportunities to make their hearing solutions more accessible to consumers.
Results from a Phase 1b/2 trial suggest that an investigational microbiome-based, oral therapeutic drug is effective for the treatment of recurrent C. difficile infection. In a paper published online in the Journal of Infectious Diseases, a multi-institutional research team reports that treatment with the preparation, containing the spores of approximately 50 species of beneficial bacteria, successfully prevented recurrence of C. difficile infection (CDI) in patients with a history of multiple recurrent disease.
Biothera will present research at the American Society of Clinical Oncology annual meeting linking a potential predictive serum biomarker to the clinical response to Imprime PGG immunotherapy in a recent phase 2 study in non-small cell lung cancer patients. The meeting begins today and runs through June 3 in Chicago.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Vinh Nguyen, MD 3151 W Tecumseh Rd Ste 230, Norman, OK 73072-1846 Ph: () - | Jason Vinh Nguyen, MD 3151 W Tecumseh Rd Ste 230, Norman, OK 73072-1846 Ph: (888) 323-3937 |
News Archive
A student-led team from The University of Texas at San Antonio is the beneficiary of a $50,000 grant to UTSA's CITE program from the National Science Foundation to support the continued development of their infrared medical camera, InfraVein, which makes simple work of finding veins.
By launching Sona, the Sonova Group is introducing a novel business concept combining a specialized product portfolio with easy fitting and simplified logistic processes, which are unique in the industry. The new brand broadens the portfolio of the established hearing solutions of Phonak and Unitron and is aimed at the market segment for mild-to-moderate hearing loss. It features mainly the integrated service concept providing audiologists with new opportunities to make their hearing solutions more accessible to consumers.
Results from a Phase 1b/2 trial suggest that an investigational microbiome-based, oral therapeutic drug is effective for the treatment of recurrent C. difficile infection. In a paper published online in the Journal of Infectious Diseases, a multi-institutional research team reports that treatment with the preparation, containing the spores of approximately 50 species of beneficial bacteria, successfully prevented recurrence of C. difficile infection (CDI) in patients with a history of multiple recurrent disease.
Biothera will present research at the American Society of Clinical Oncology annual meeting linking a potential predictive serum biomarker to the clinical response to Imprime PGG immunotherapy in a recent phase 2 study in non-small cell lung cancer patients. The meeting begins today and runs through June 3 in Chicago.
› Verified 2 days ago
Harold Jackson Woodward Jr., MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2201 Mckown Dr, #1, Norman, OK 73072 Phone: 405-329-5613 Fax: 405-360-7747 | |
Joshua Trent Powell, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 816 24th Ave Nw, Norman, OK 73069 Phone: 405-286-3937 Fax: 405-701-8407 | |
Robert Daniel Bales, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 809 N Findlay Ave, Suite 105, Norman, OK 73071 Phone: 405-701-1122 Fax: 405-701-1151 | |
Dr. Joel C Razook, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2300 36th Ave Nw, Suite 110, Norman, OK 73072 Phone: 405-579-7664 Fax: 405-321-3193 | |
Dr. Kimberly Marie Wise, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2201 Mckown Dr, Norman, OK 73072 Phone: 405-329-5613 Fax: 405-360-7747 |